Blood test may predict chemo failure in aggressive breast cancer
Knowledge-focused
Recruiting now
This study looks at 42 women with triple negative breast cancer, an aggressive type that lacks targeted treatments. Participants receive standard chemotherapy, and researchers will measure tiny molecules in the blood (microRNA and tumor DNA) to see if changes can signal when the …
Phase: PHASE2 • Sponsor: University College Hospital, Ibadan • Aim: Knowledge-focused
Last updated May 09, 2026 05:20 UTC